Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Nam Phong Nguyen, MD

LICENSE # 0101051955
 
Issue Date: 12/30/1994
Expiration Date: 10/31/2024
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 9/10/2022
Howard University College Of Medicine - Washington DC
Rank: Full Professor
Years: 2014-present

Academic Appointments - Non-US
Last Updated 9/10/2022
University of Arizona
Rank: Associate Professor
Years: 2007-2012
Publications
(up to ten in the last five years)
Last Updated 9/10/2022
Hepatosplenic candidiasis in patients with acute leukemia
British J of Haenatology
Volume: 106
Date: 01 1999

Acquired hemophilia in patients with hematologic malignancies
Arch Pathology &Lab Medicine
Volume: 124
Date: 01 2000

Autoimmune hemolytic anemia in patients with non Hodgkin's lymphoma
Ann Oncology
Volume: 11
Date: 01 2000

Combined chemotherapy and radiation for the treatment of locally advanced head and neck malignancies
In Vivo
Volume: 14
Date: 01 2000

Low dose radiation therapy for spinal cord compression in neuroblastoma
Anticancer Research
Volume: 20
Date: 01 2000

Preoperatice chemoradiation for the treatment of locally advanced rectal carcinoma
Am J of Clinical Oncology
Volume: 23
Date: 01 2000

Interferon combined with radiotherapy in the treatment of unresectable melanoma
Cancer Investigation
Volume: 19
Date: 01 2001

Treatment of refractory T-cell malignancies using Gemcitabine
Br. J. Haematology
Volume: 113
Date: 01 2001

Long-term aspiration following treatment of head and neck cancer
Oncology (Karger)
Date: 06 2008

Can stereotactic body radiation become the standard of care for early stages non-small cell carcinoma
Cancer Treatment Reviews
Date: 07 2008